Possible role of metabolite in flosequinan-related mortality

被引：4

作者：

Kamali, F

Edwards, C

机构：

[1] Wolfson Unit of Clinical Pharmacology, University of Newcastle Upon Tyne, Newcastle Upon Tyne

来源：

CLINICAL PHARMACOKINETICS | 1995年 / 29卷 / 06期

关键词：

D O I：

10.2165/00003088-199529060-00002

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

[No abstract available]

引用

页码：396 / 403

页数：8

共 34 条

[1]

[Anonymous], 1989, NEW ENGL J MED, V321, P406

[2] PREDICTION OF CREATININE CLEARANCE FROM SERUM CREATININE [J].

COCKCROFT, DW ;

GAULT, MH .

NEPHRON, 1976, 16 (01) :31-41

[3] A COMPARISON OF ENALAPRIL WITH HYDRALAZINE ISOSORBIDE DINITRATE IN THE TREATMENT OF CHRONIC CONGESTIVE-HEART-FAILURE [J].

COHN, JN ;

JOHNSON, G ;

ZIESCHE, S ;

COBB, F ;

FRANCIS, G ;

TRISTANI, F ;

SMITH, R ;

DUNKMAN, WB ;

LOEB, H ;

WONG, ML ;

BHAT, G ;

GOLDMAN, S ;

FLETCHER, RD ;

DOHERTY, J ;

HUGHES, CV ;

CARSON, P ;

CINTRON, G ;

SHABETAI, R ;

HAAKENSON, C .

NEW ENGLAND JOURNAL OF MEDICINE, 1991, 325 (05) :303-310

[4]

DUPONT AG, 1989, CURR THER RES CLIN E, V46, P423

[5]

FIRTH B, 1989, UF89009 BOOTS CO PLC

[6] PHARMACOKINETIC PROFILE OF FLOSEQUINAN IN PATIENTS WITH COMPROMISED RENAL-FUNCTION [J].

GALLO, BV ;

HINSON, JL ;

WEIDLER, DJ .

JOURNAL OF PHARMACEUTICAL SCIENCES, 1993, 82 (03) :282-285

[7]

HAMPTON DM, 1990, UF90006 BOOTS CO INC

[8]

HIND ID, 1990, DT89025 BOOTS CO PLC

[9]

HIND ID, 1990, DT89021 BOOTS CO PLC

[10]

HIND ID, 1990, DT89023 BOOTS CO PLC

← 1 2 3 4 →